Microbiological diagnostic testing in the treatment of periodontal diseases
Microbiological diagnostic testing in the treatment of periodontal diseases
复制标题
DOI:
10.1046/j.0906-6713.2002.003424.x
复制
发表时间:
2004-01-01
影响因子:
18.6
通讯作者:
Loomer, PM
中科院分区:
文献类型:
--
作者:
Loomer, PM
The initiation and progression of periodontal disease is attributed to the presence of elevated levels of pathogenic bacteria within the gingival crevice (70, 71). Several hundred recognized species of microorganisms, and many more that have yet to be identified, inhabit the gingival crevice; however, it has been shown that only a few play significant roles in the etiology of periodontal diseases. This evidence is largely based on epidemiologic data, the ability of a microorganism to produce disease when introduced into animals, and the capacity to produce virulence factors. However, the mere presence of putative periodontopathogens in the gingival crevice is not in itself sufficient to initiate or cause periodontal inflammation. What is essential is that there be an elevation in their relative proportions such that a critical mass is present to mount an effective tissue-damaging response. Indeed, even in health, periodontopathogenic microorganisms are present in the gingival crevice, albeit in low numbers, as members of the normal resident flora. The overwhelming majority of patients with chronic periodontitis, despite their diverse oral microbiological profiles, respond remarkably well to traditional mechanical methods of periodontal treatment (ie oral hygiene instructions, scaling and root planing, and surgery). For these patients, a sustainable reduction in the total level of periodontopathogenic bacteria in their pockets, through professional and personal plaque control, is usually adequate to stop the progression of the disease. However, there are some patients who do not respond well to traditional periodontal therapy. These patients are sometimes referred to as``refractory''to treatment. They continue to lose clinical attachment despite having received periodontal therapy that succeeds in most patients. In addition, they usually have good oral hygiene and comply with recommended periodontal maintenance/recall schedules. Conceptually, patients with refractory chronic periodontitis have a persistent infection that will most likely require diagnostic and treatment approaches beyond those that have already been tried. One of these approaches follows a medical model where microbiological testing is performed on a clinical sample, putative pathogens are identified, and an appropriate antibiotic is administered. Since most periodontal diseases are mixed infections, microbiologic testing is done for a battery of possible pathogens. Microbiologic tests have been developed to identify selected periodontopathogenic microorganisms in the gingival sulcus. These tests provide information that can help guide the clinician in determining whether or not an antimicrobial agent, and which particular one, may provide an additional therapeutic benefit for the patient. Several different types of microbiological tests are available. The utility of these tests for patients who have not responded to conventional therapy, as well as their usefulness in monitoring patients on maintenance therapy for recurrence of disease will be discussed in this chapter.